Virology Unit, Department of Translational Medicine, Novara Medical School, Novara 28100, Italy; and.
Viral Pathogenesis Unit, Department of Public Health and Pediatric Sciences, Turin Medical School, Turin 10126, Italy.
J Immunol. 2018 Mar 15;200(6):2076-2089. doi: 10.4049/jimmunol.1701536. Epub 2018 Jan 31.
Although it is clear that high-risk human papillomaviruses (HPVs) can selectively infect keratinocytes and persist in the host, it still remains to be unequivocally determined whether they can escape antiviral innate immunity by interfering with pattern recognition receptor (PRR) signaling. In this study, we have assessed the innate immune response in monolayer and organotypic raft cultures of NIKS cells harboring multiple copies of episomal HPV18 (NIKSmcHPV18), which fully recapitulates the persistent state of infection. We show for the first time, to our knowledge, that NIKSmcHPV18, as well as HeLa cells (a cervical carcinoma-derived cell line harboring integrated HPV18 DNA), display marked downregulation of several PRRs, as well as other PRR downstream effectors, such as the adaptor protein stimulator of IFN genes and the transcription factors IRF1 and 7. Importantly, we provide evidence that downregulation of stimulator of IFN genes, cyclic GMP-AMP synthase, and retinoic acid-inducible gene I mRNA levels occurs at the transcriptional level through a novel epigenetic silencing mechanism, as documented by the accumulation of repressive heterochromatin markers seen at the promoter region of these genes. Furthermore, stimulation of NIKSmcHPV18 cells with salmon sperm DNA or poly(deoxyadenylic-deoxythymidylic) acid, two potent inducers of PRR signaling, only partially restored PRR protein expression. Accordingly, the production of IFN-β and IFN-λ was significantly reduced in comparison with the parental NIKS cells, indicating that HPV18 exerts its immunosuppressive activity through downregulation of PRR signaling. Altogether, our findings indicate that high-risk human papillomaviruses have evolved broad-spectrum mechanisms that allow simultaneous depletion of multiple effectors of the innate immunity network, thereby creating an unreactive cellular milieu suitable for viral persistence.
尽管已经明确高危型人乳头瘤病毒(HPV)可以选择性地感染角质形成细胞并在宿主中持续存在,但仍需要明确它们是否可以通过干扰模式识别受体(PRR)信号来逃避抗病毒固有免疫。在这项研究中,我们评估了含有多个 HPV18 (NIKSmcHPV18) episomal 的 NIKS 细胞单层和器官样筏培养物中的固有免疫反应,该细胞完全再现了持续性感染状态。我们首次表明,NIKSmcHPV18 以及 HeLa 细胞(一种含有整合 HPV18 DNA 的宫颈癌细胞系)显著下调了几种 PRR 以及其他 PRR 下游效应子,如干扰素基因刺激物衔接蛋白和转录因子 IRF1 和 7。重要的是,我们提供的证据表明,干扰素基因刺激物、环鸟苷酸-AMP 合酶和维甲酸诱导基因 I mRNA 水平的下调是通过一种新的表观遗传沉默机制发生在转录水平上的,这可以通过在这些基因的启动子区域观察到的抑制性异染色质标记物的积累来证明。此外,用鲑鱼精 DNA 或聚(脱氧腺苷-脱氧胸苷)酸刺激 NIKSmcHPV18 细胞,这两种 PRR 信号的强诱导剂,仅部分恢复了 PRR 蛋白表达。因此,与亲本 NIKS 细胞相比,IFN-β和 IFN-λ 的产生显著减少,表明 HPV18 通过下调 PRR 信号发挥其免疫抑制活性。总之,我们的研究结果表明,高危型人乳头瘤病毒已经进化出广谱机制,允许同时耗尽固有免疫网络的多个效应子,从而创造出适合病毒持续存在的无反应性细胞环境。